Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Synergy has been actively involved in medical technology and venture capital since 1996. We have participated in over $800 million in equity and other financial transactions for over 70 private U.S. medical technology companies through equity investment from our Synergy Ventures funds, and, through Synergy Partners International, establishment of strategic alliances, investments, or acquisitions involving US medical device companies and leading Japan medical device corporations. Synergy Ventures seeks early stage investment opportunities in US medical device startups, with typical funding levels of $250K to $1M in our initial investment.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2016 | Respirix | Convertible Note | 1.5M |
7/2018 | Cue | Series B | 0 |
3/2000 | Fastparts | Series D | 0 |
4/2000 | Always-On Software | Series B | 10.7M |
5/2007 | Bioabsorbable Therapeutics | Series B | 0 |
4/2000 | TheSquare.com | Series A | 0 |
12/2009 | TruTouch Technologies | Venture Round | 0 |
7/2018 | Cagent Vascular | Series B | 11.9M |
10/2011 | CV Ingenuity | Series B | 16M |
7/2000 | Fast-Chip | Series B | 11M |
3/2000 | AdFlight | Series A | 8.3M |
6/2018 | Paradromics | Seed Round | 7M |
7/2021 | Paradromics | Seed | 20M |
7/2021 | Paradromics | Seed Round | 0 |
7/2018 | Cagent Vascular | Series B | 0 |
7/2018 | Cue | Series B | 0 |
6/2018 | Paradromics | Seed Round | 0 |
2/2016 | Respirix | Convertible Note | 0 |
10/2011 | CV Ingenuity | Series B | 0 |
12/2009 | TruTouch Technologies | Venture Round | 0 |
5/2007 | Bioabsorbable Therapeutics | Series B | 0 |
7/2000 | Fast-Chip | Series B | 0 |
4/2000 | TheSquare.com | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|